Trademark: 97704083
Word
OUTLAST
Status Date
Monday, April 22, 2024
Filing Date
Monday, December 5, 2022
Published for Opposition
Tuesday, September 5, 2023
5 Biological preparations, namely, preparations for use in the treatment of cancer; biologic preparations for medical and therapeutic purposes for immunotherapy; biological preparations for immunotherapy, namely, T-Cell therapy; cells for medical or clinical use; pharmaceutical preparations and therapeutic agents for the treatment of cancer; medical diagnostic reagents for the treatment of cancer; therapeutic preparations in the nature of an engineered cell therapy platform consisting of CAR-T cells for the treatment of cancer; biotechnology platform for the treatment of cancer through developing and engineering therapeutic cells, consisting of CAR-T cells, therapeutic medical antibodies, therapeutic agents and cellular function activating agents; clinical medical reagents for the treatment of cancer
1 Reagents for research purposes, drug discovery and development; Reagents for clinical cancer treatment research; biotechnology platform for developing and engineering therapeutic cells for drug research and development, consisting of therapeutic proteins and therapeutic antibodies for the treatment of cancer; biotechnology platform for developing and engineering therapeutic cells, consisting of CAR-T cells, therapeutic medical antibodies, therapeutic agents and cellular function activating agents for the treatment of cancer
Jan 10, 2023
Non-Final Action E-Mailed
Dec 8, 2022
New Application Entered
Dec 8, 2022
New Application Office Supplied Data Entered
Dec 24, 2022
Assigned To Examiner
Jan 10, 2023
Non-Final Action Written
Jan 10, 2023
Notification Of Non-Final Action E-Mailed
Apr 10, 2023
Application Extension To Response Period - Received
Apr 10, 2023
Application Extension Granted/Receipt Provided
May 17, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 17, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
May 17, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
May 17, 2023
Teas Change Of Correspondence Received
Jun 8, 2023
Examiners Amendment -Written
Jun 8, 2023
Examiners Amendment E-Mailed
Jun 8, 2023
Notification Of Examiners Amendment E-Mailed
Jun 8, 2023
Examiner's Amendment Entered
Jun 13, 2023
Teas Response To Office Action Received
Jun 13, 2023
Correspondence Received In Law Office
Jul 26, 2023
Teas/Email Correspondence Entered
Aug 1, 2023
Approved For Pub - Principal Register
Aug 16, 2023
Notification Of Notice Of Publication E-Mailed
Sep 5, 2023
Published For Opposition
Sep 5, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 31, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 22, 2024
Sou Extension 2 Granted
Apr 22, 2024
Sou Teas Extension Received
Apr 22, 2024
Sou Extension 1 Filed
Apr 22, 2024
Sou Extension 1 Granted
Apr 23, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
